BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20607351)

  • 1. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience.
    Díez Valle R; Tejada Solis S; Idoate Gastearena MA; García de Eulate R; Domínguez Echávarri P; Aristu Mendiroz J
    J Neurooncol; 2011 Mar; 102(1):105-13. PubMed ID: 20607351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
    Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
    Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
    Bettag C; Schregel K; Langer P; Thomas C; Behme D; Stadelmann C; Rohde V; Mielke D
    Neurosurg Focus; 2021 Jan; 50(1):E3. PubMed ID: 33386004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.
    Stummer W; Novotny A; Stepp H; Goetz C; Bise K; Reulen HJ
    J Neurosurg; 2000 Dec; 93(6):1003-13. PubMed ID: 11117842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.
    Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M
    Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of ventricular wall fluorescence during 5-aminolevulinic-guided surgery for glioblastoma.
    Tejada-Solís S; Aldave-Orzaiz G; Pay-Valverde E; Marigil-Sánchez M; Idoate-Gastearena MA; Díez-Valle R
    Acta Neurochir (Wien); 2012 Nov; 154(11):1997-2002; discussion 2002. PubMed ID: 22930281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.
    Aldave G; Tejada S; Pay E; Marigil M; Bejarano B; Idoate MA; Díez-Valle R
    Neurosurgery; 2013 Jun; 72(6):915-20; discussion 920-1. PubMed ID: 23685503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma.
    Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K-
    Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
    Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
    Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
    Müther M; Koch R; Weckesser M; Sporns P; Schwindt W; Stummer W
    Neurosurgery; 2019 Dec; 85(6):E1020-E1029. PubMed ID: 31215632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.
    Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu HK; Shim H; Hadjipanayis CG
    Mol Imaging Biol; 2016 Jun; 18(3):454-62. PubMed ID: 26463215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.
    Pichlmeier U; Bink A; Schackert G; Stummer W;
    Neuro Oncol; 2008 Dec; 10(6):1025-34. PubMed ID: 18667747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral Radiance of Protoporphyrin IX Fluorescence and Its Histopathological Implications in 5-Aminolevulinic Acid-Guided Surgery for Glioblastoma.
    Yoneda T; Nonoguchi N; Ikeda N; Yagi R; Kawabata S; Furuse M; Hirose Y; Kuwabara H; Tamura Y; Kajimoto Y; Kuroiwa T
    Photomed Laser Surg; 2018 May; 36(5):266-272. PubMed ID: 29480754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
    Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A
    Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
    Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
    J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluorescence guided resection of malignant brain tumors - breakthrough in the surgery of brain tumors].
    Gautschi OP; van Leyen K; Cadosch D; Hildebrandt G; Fournier JY
    Praxis (Bern 1994); 2009 Jun; 98(12):643-7. PubMed ID: 19513974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.